Flexion Therapeutics (FLXN)

9.12  -0.02 (-0.22%)

After market: 9.121 +0 (+0.01%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2018 2019 2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
22.52M
6,155.56%		72.96M
223.98%		85.55M
17.26%		110.157M
EBITDA
YoY % growth
-157.49M
-23.36%		-135.21M
14.15%		-91.32M
32.46%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
-159.2M
-22.76%		-136.27M
14.40%		-93.02M
31.74%		N/AN/AN/AN/AN/A
Operating Margin
-706.93%-186.77%-108.73%N/AN/AN/AN/AN/A
EPS
YoY % growth
-4.48
-7.69%		-3.93
12.28%		-2.61
33.59%		-2.11

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 21 Q1 / 22 Q2 / 22 Q3 / 22 Q4 / 22
EPS
Q2Q % growth		-0.48
Revenue
Q2Q % growth		31.624M
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		N/AN/AN/AN/AN/A

Recent Earnings VS Estimates Surprises ()
PeriodReportedEstimateDifferenceSurprise
Q2 2021
Q2Q % growth		 -0.44
42.11%		-0.510.0713.93%
Q1 2021
Q2Q % growth		 -0.57
40.00%		-0.53-0.04-7.33%
Q4 2020
Q2Q % growth		 -0.40
54.55%		-0.450.0510.91%
Q3 2020
Q2Q % growth		 -0.50
50.00%		-0.520.024.68%
Recent Revenue VS Estimates Surprises

Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .

PeriodReportedEstimateDifferenceSurprise
Q3 2021
Q2Q % growth		 21.326M
-9.86%		24.77M-3.444M-13.90%
Q2 2021
Q2Q % growth		 28.175M
82.36%		29.588M-1.413M-4.78%
Q1 2021
Q2Q % growth		 24.59M
22.16%		25.269M-678.797K-2.69%
Q4 2020
Q2Q % growth		 26.31M
11.25%		26.912M-601.507K-2.24%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A